This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Talk:MMDA: Difference between revisions
>Blackhole |
>Yzgzs →Chemistry: Added content |
||
| (10 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{headerpanel|{{approval}}}} | |||
{{SummarySheet}} | {{SummarySheet}} | ||
{{SubstanceBox/MMDA}} | {{SubstanceBox/MMDA}} | ||
| Line 158: | Line 159: | ||
There is an increased risk of serotonin syndrome when MMDA is taken with many antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). Additionally, if MMDA is taken with SSRIs and SNRIs, the MMDA will be significantly less powerful or may have no distinguishable effects at all. | There is an increased risk of serotonin syndrome when MMDA is taken with many antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). Additionally, if MMDA is taken with SSRIs and SNRIs, the MMDA will be significantly less powerful or may have no distinguishable effects at all. | ||
==Legal | ==Legal status== | ||
{{LegalStub}} | {{LegalStub}} | ||
*'''UK:''' MMDA is a Class A drug.{{citation needed}} | *'''UK:''' MMDA is a Class A drug.{{citation needed}} | ||
*'''China:'''MMDA is a Schedule I controlled substance | |||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
| Line 173: | Line 174: | ||
*[[wikipedia:MMDA (drug)|MMDA (drug) (Wikipedia)]] | *[[wikipedia:MMDA (drug)|MMDA (drug) (Wikipedia)]] | ||
*[https://isomerdesign.com/PiHKAL/explore.php?id=132 MMDA (Isomer Design)] | *[https://isomerdesign.com/PiHKAL/explore.php?id=132 MMDA (Isomer Design)] | ||
*[https://go.drugbank.com/drugs/DB01442 MMDA (DrugBank)] | |||
*[http://www.rollsafe.org/ RollSafe] | *[http://www.rollsafe.org/ RollSafe] | ||